The Paragonix SherpaPak devices for kidney and heart preservation are an important step in improving medical health donor organ transportation. We believe that improving the utilization of donated organs is critical to patients in end-stage organ failure who are desperate for this precious commodity. Previous Announcements Paragonix previously announced November 9, 2016 an exclusive distribution agreement with Pacific West Medical Sales for Paragonix SherpaPak Cardiac and Kidney Transport Systems in California Paragonix previously announced June 29, 2016 a Product Supply Agreement with Waters most valuable Medical Systems LLC, for Waters IGL and Celsior Cold Storage Solutions for Use With the SherpaPak Kidney Transport System and SherpaPak Cardiac Transport System Paragonix and Essential Pharmaceuticals LLC previously announced June 28, 2016, a Product Supply Agreement for Custodiol HTK Organ Preservation Solution for Use With the SherpaPak Cardiac Transport System and SherpaPak Kidney Transport System Paragonix previously announced June 6, 2016, Presentation of the SherpaPak Cardiac Transport System during the 2016 American Transplant Congress June 11 – 15, 2016 in Boston, MA Paragonix previously announced on July 23, 2015, Publication of Innovative Cold Storage Of Donor Organs Using The Paragonix SherpaPak Devices”1 Paragonix previously announced on February 9, 2015, Innovative Tracking Technology For Real-Time, National Location Tracking of Donor Organs Paragonix previously announced on December 2, 2014, clearance of two 510(k) Premarket Notifications by the US Food and Drug Administration, allowing the cheers Paragonix Sherpa Pak Transport Systems to be combined and distributed with any FDA-cleared, commercially-available preservation solution Paragonix previously announced on Nov 17, 2014, Receipt of ISO 13485:2003 Certification for the Paragonix Sherpa Organ Storage and Transport Systems Paragonix previously announced on Nov 3, 2014, filing of two 510(k) FDA Pre-Market Notifications to combine the Paragonix Sherpa Pak Cardiac and Kidney Transport Systems with any effective organ preservation solution currently marketed under 510(k) Pre-market Clearance Paragonix previously announced on Oct 27, 2014, joining of David DAlessandro, MD, as Medical Director for Paragonix About Bio Instruments, LLC Bio Instruments, LLC was founded in 1978. The Company represents the upper Midwestspecializing in products for Cardiac, Vascular, and Thoracic procedures. About the Paragonix SherpaPak and SherpaPerfusion Cardiac Transport System Currently, the availability of cardiac transplantation is governed by the ischemic time, that being, the elapsed time from heart donation to recipient implantation. According to The International Society Of Heart and Lung Transplantation (ISHLT) guidelines2 for the care of heart transplant recipients, the projected ischemic time should not exceed 4 hours3,4, limiting the distance available to transport a donor heart. Paragonix SherpaPak Cardiac Transport System is fully disposable, eliminating problems associated with maintenance, device transport and contamination. The Paragonix SherpaPerfusion Cardiac Transport System combines innovative oxygenated perfusion of organs and safe organ storage with the ultimate goal of extending ischemic time to 12 hours, significantly altering the transportation range of donor hearts. Read More About Paragonix Technologies, Inc. Based in Massachusetts and founded in 2010, Paragonix Technologies Inc., is a privately held medical device company innovating the Paragonix SherpaPak and SherpaPerfusion Cardiac Transport System, a novel, single-use organ preservation device to improve donor organ quality. Paragonix has established a pipeline of donor organ transport devices that address the current donor organ shortage by maximizing donor organ utilization, improving donor organ quality and extending donor organ transport throughout the entire United States. 1 Michel et al.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/paragonix-technologies-inc-bio-instruments-110000353.html
Deadline for submitting an application is Jan. 20. Applications are kept on file for current year only. Holiday garbage, recycling rules set With the Christmas and New Years holidays upon us, Johnson City Solid Waste customers are reminded that garbage and recycling collection will be on a regular schedule this year. Additionally, citizens are asked to please recycle their gift boxes, cardboard packaging and paper. The city does not accept foil paper or most plastic packaging. Plastic marked with a 1 or 2 is acceptable. For added convenience, the city offers five drop-off sites for recyclables. Visit http://www.johnsoncitytn.org/publicworks/solidwaste/recycling for more information and locations.
For the original version including any supplementary images or video, visit http://www.johnsoncitypress.com/Community/2016/12/25/Happenings-in-your-community-165.html
began tested Henry’s blood. Mayo Clinic, Rochester, Thanking You Finn. Recommended SiteKidney cancer, a type of cancer that starts in your kidneys, can happen in adults and children. The kidneys allow consumption of a variety of foods, drugs, vitamins, dietary and herbal supplements, food additives, and excess fluids without worry that toxic by-products will build up to harmful levels. Your doctor will decide which is right for you. Drink throughout the day. The curvy first section of the renal tubule is known as the proximal convoluted tubule. This primarily occurs through maintenance of the extracellular fluid compartment, the size of which depends on the plasma sodium concentration. One way is by producing a blood vessel-constricting protein angiotensin that also signals the body to retain sodium and water. Cleaned blood returns to the body by the renal vein. Renal sinus • 15. Considering their importance, eating a diet to promote kidney health could be one of the best things you can do.